Monoclonal Antibodies Dominate Protein Therapeutics Market

Noida, India (PressExposure) January 01, 2010 -- The protein therapeutics market represents one of the most promising sectors in the global pharmaceutical industry. The sector has seen double-digit growth in recent years and with a strong efficacy and more specific activity to target diseases, the growth is likely to sustain in future too. According to our latest research on the sector called “Global Protein Therapeutics Market Analysis”, the market for protein therapeutics is forecast to grow at a CAGR of around 12% during 2010-2012.

Our research provides extensive analysis and information on different regional level markets. We have identified certain key country-level markets where the industry is expected to perform exceptionally well in future. Also, the report analyzes various aspects of the industry along with several macro and micro economic factors, which are giving support to the growth of these markets.

We have done a thorough analysis of different segments like Monoclonal antibodies, EPO, Insulin, Interferon, Human growth hormone and FSH. Our report extensively discusses various factors that are driving the growth of these segments and provides a rational analysis of these factors. We have found that the monoclonal antibodies are currently dominating the market and will retain their dominance in near future also. Our research also states the use of monoclonal antibodies in the treatment of different diseases as well as their possible market size.

“Global Protein Therapeutics Market Analysis” identifies and defines protein therapeutics market in a way that helps clients in understanding the technical aspects of the industry. The forecasts given in the report are based on past and present market trends, statistical analysis and industry drivers and give a direction to the clients in which the industry is likely to move. It will also help clients in identifying the prevailing opportunities and will give them a suitable direction to tap the opportunities in global protein therapeutics industry.

For FREE SAMPLE of this report visit: []


About RNCOS E-Services Pvt. Ltd.

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Press Release Source:

Press Release Submitted On: January 01, 2010 at 12:58 am
This article has been viewed 11512 time(s).